The molecular quality controls market is projected to reach USD 0.3 billion by 2028 from USD 0.2 billion in 2023, at a CAGR of 6.6% during the forecast period. Growth in this market is majorly driven by the increasing number of accredited clinical laboratories, growing adoption of third-party quality controls, and increasing government funding for genomic projects. Rising demand for multi-analyte controls and growth opportunities in emerging countries are expected to offer opportunities for market players during the forecast period.
The prominent players in molecular quality controls market are Microbiologics, Inc. (US), Steck LLC (US), Helena Laboratories Corporation (US), Microbix Biosystems Inc. (Canada), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Anchor Molecular (US), Fortress Diagnostics (UK), SERO AS (Norway), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Anchor Molecular (US), Vircell S.L. (Spain), Ortho Clinical Diagnostics, Inc. (US), QuidelOrthoCorporation (US), Sun Diagnostics, LLC (US), Molbio Diagnostics Pvt. Ltd. (India), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US), and Grifols, S.A. (Spain).
To know about the assumptions considered for the study download the pdf brochure
LGC Limited is a leading global provider of life science tools across the human healthcare and applied market segments. The company offers products through its Clinical and Molecular Diagnostics, Pharma and Biotech, Research and Government, and Applied segments. In November 2018, LGC Group acquired SeraCare Life Sciences, Inc. The LGC Group now offers quality control products through its SeraCare Life Sciences division. The company offers quality control solutions to IVD assay developers, manufacturers, and clinical laboratories, including reference materials, calibration verification materials, controls, immunoassay reagents, processed plasma and serum products, and proficiency testing. SeraCare Life Sciences, Inc. is the leader in the molecular quality controls market. It provides a wide range of quality controls and reference materials under its flagship brands– Sreaseq and ACCURUN. The company also offers technical support, training for its diagnostic kits and customer support services to various end users. SeraCare provides assurance in test results for infectious disease identification, non-invasive prenatal testing and oncology with its advanced quality control technology.
Thermo Fisher Scientific is a leading provider of diagnostic solutions and offers a wide portfolio of quality controls for clinical chemistry, molecular diagnostics, and microbiology testing. Owing to its strong sales and distribution network, the company has a significant global footprint. It uses a multi-channel approach, including direct sales, electronic commerce, resellers, manufacturers’ representatives, and distributors to market its products and services to its end users. Thermo Fisher majorly focuses on organic strategies such as product launches to enhance its product offerings. Furthermore, its extensive R&D investments enable it to provide innovative products and solutions in the market space. The company intends to adopt new technologies and partner with new businesses to complement its existing business segments. Such developments will enable Thermo Fisher to add innovative technologies and products to its portfolio, which, in turn, will help strengthen its presence in the molecular quality controls market.
Bio-Rad Laboratories, Inc. is one of the leaders in the molecular quality controls market. The company offers more than 3,000 products covering more than 300 clinical diagnostic tests. It has a wide range of product offerings for the Clinical Diagnostics segments and Life Science. To maintain its leading position in this market, the company has adopted inorganic growth strategies such as acquisitions and partnerships. With its wide distribution network and strong geographic presence, Bio-Rad Laboratories has established itself in a leading position in the global quality controls market.
Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control (PCR, DNA Sequencing), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE